Page last updated: 2024-11-04

sulfasalazine and Histiocytoma, Benign Fibrous

sulfasalazine has been researched along with Histiocytoma, Benign Fibrous in 1 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Histiocytoma, Benign Fibrous: A benign tumor composed, wholly or in part, of cells with the morphologic characteristics of HISTIOCYTES and with various fibroblastic components. Fibrous histiocytomas can occur anywhere in the body. When they occur in the skin, they are called dermatofibromas or sclerosing hemangiomas. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 5th ed, p1747)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beyazit, Y1
Caner, S1
Kurt, M1
Kekilli, M1
Aydog, G1
Ibis, M1

Other Studies

1 other study available for sulfasalazine and Histiocytoma, Benign Fibrous

ArticleYear
Dermatofibroma in a patient with Crohn's disease: a novel clinical manifestation.
    Journal of Crohn's & colitis, 2010, Volume: 4, Issue:4

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Drug Therapy, Combination; Female; Gl

2010